MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • MDS Virtual Congress 2021

    Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies

    R. Rosales, L. Cuffe, B. Regnault, R. Trosch (Manila, Philippines)

    Objective: The aim of this meta-analysis of pivotal studies was to evaluate the efficacy of abobotulinumtoxinA (AboBoNT-A) in reducing pain in patients with cervical dystonia…
  • MDS Virtual Congress 2020

    Thalamic Deep Brain Stimulation for Acquired Dystonia in Children and Young Adults: A Phase I Clinical Trial

    M. San Luciano, A. Viehoever, I. Bledsoe, K. Dodenhoff, M. Gittings, A. Viser, C. Racine-Belkoura, C. Pereira, S. Wang, P. Starr, J. Ostrem (San Francisco, CA, USA)

    Objective: To evaluate preliminary efficacy and safety of bilateral ventralis oralis posterior (VOP) deep brain stimulation (DBS) for the treatment of acquired dystonia in children…
  • MDS Virtual Congress 2020

    O-arm stereotactic imaging in deep brain stimulation surgery workflow: A utility and cost-effectiveness analysis

    L. Furlanetti, H. Hasegawa, A. Oviedova, A. Raslan, M. Samuel, R. Selway, K. Ashkan (London, United Kingdom)

    Objective: This study aimed to evaluate the safety and feasibility of using the Medtronic O-arm device for the acquisition of intraoperative stereotactic imaging, targeting, and…
  • MDS Virtual Congress 2020

    The effect of botulinum toxin A on pain associated with cervical dystonia (CD) in routine clinical practice

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: To evaluate the effect of abobotulinumtoxinA (aboBoNT-A) on pain associated with cervical dystonia (CD) in routine clinical practice. Background: Pain is considered as the…
  • MDS Virtual Congress 2020

    FL-41 Lenses for the Treatment of Meige Syndrome

    A. Vickers, A. Lee, T. Campbell (Las Vegas, NV, USA)

    Objective: A case report demonstrating successful treatment of Meige syndrome with FL-41 rose-tinted lenses. Background: Meige syndrome is a rare disorder characterized by blepharospasm and…
  • MDS Virtual Congress 2020

    Botolinum Toxin A in a 33-year old Multigravid Filipino with Dystonia Gravidarum: A Case Report

    G. Vista, J. Vatanagul, K. Sia (Cebu, Philippines)

    Objective: This paper aims to present a rare case of dystonia gravidarum using Botolinum Toxin A as treatment. Background: Dystonia is a rare event in…
  • MDS Virtual Congress 2020

    Idiopathic cervical dystonia – does autoimmunity play a hand?

    A. Panwar, N. Sawal, D. Garg, R. Kaur (Chandigarh, India)

    Objective: To evaluate efficacy of immunosuppression using glucocorticoids in 2 patients of recently diagnosed cervical dystonia(CD). Background: Most cases of CD are idiopathic. Most effective…
  • MDS Virtual Congress 2020

    Unlocking dystonia from Parkinson’s disease (PD) with directional deep brain stimulation (DBS)

    R. Vaden, A. Nakhmani, C. Hurt, C. Gonzalez, B. Guthrie, H. Walker (Birmingham, AL, USA)

    Objective: To investigate dystonia associated with PD in patients undergoing unilateral subthalamic nucleus (STN) DBS implantation. Background: Dystonia is a twisting, involuntary movement that often…
  • MDS Virtual Congress 2020

    Stimulation induced dystypia after pallidal deep brain stimulation

    J. Wong, M. Armstrong, L. Almeida, M. Okun, I. Malaty (Gainesville, FL, USA)

    Objective: _ Background: Typing on a keyboard requires complex collaboration between visuospatial procedural memory, language and motor function [1,2]. The impaired ability to type, independent…
  • MDS Virtual Congress 2020

    Pridopidine for the Treatment of Early Huntington’s Disease

    M. Geva, R. Reilmann, C. Olanow, M. Leinonen, Y. Cohen, P. Meyer, A. McGarry, O. Sabri, M. Hayden, K. Kieburtz (Herzliya, Israel)

    Objective: Assess the efficacy of pridopidine 45 mg bid for maintenance of total functional capacity (TFC) and motor function in early HD patients. Background: Pridopidine…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley